366 results
Is a hospital-at-home model with comprehensive geriatric assessment (CGA) an alternative to hospital admission for older adults? Read this EBM Focus article to find out.
With the rising number of antitransgender bills aiming to limit care for transgender adolescents, DynaMed® editors evaluate the science behind gender-affirming care for transgender youth.
Insulin therapy should be considered for patients with type 2 diabetes who are unable to maintain glycemic goals with diet and glucose-lowering medications.
Durability of immunity and risk of reinfection with SARS-CoV-2 is an important area of research, but what do the studies actually tell us about protection against COVID-19?
In this EBM Focus article, DynaMed® editors discuss the impressive effects of semaglutide on weight loss and the limitations of this new study.
With millions of people around the world vaccinated with an mRNA-based vaccine for COVID-19, here’s a sneak peek into the body to see how they work.
Explore GIDEON’s user-centric approach to transforming its interface to meet the diverse needs of modern clinical and academic users. Read a first-hand account from GIDEON Director, Product Development and Marketing, Kristina Symes.
Antiviral monoclonal antibody therapy is authorized for outpatients with mild-to-moderate COVID-19 at high risk for clinical progression. Read about this new therapy from the Infectious Disease team at DynaMed®.
Read about a new trial evaluating sotagliflozin in patients with diabetes and worsening heart failure, including threats to validity when protocols were amended mid-study.
Seven different COVID-19 vaccines are authorized around the world. Read about availability, vaccine types, vaccine efficacy, variants and vaccination precautions from the Infectious Disease team at DynaMed®.